AnX Robotica, a leader in advanced gastrointestinal visualization technologies, recently announced the publication of a study validating the clinical benefits of their ProScan AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy. The study, titled AI-assisted capsule endoscopy reading in suspected small bowel bleeding: a multicentre prospective study, published in Lancet Digital Health, concluded that the ProScan technology is faster and more accurate in diagnosing small bowel bleeding. The findings demonstrated an increased diagnostic yield and significantly higher lesion detection rate, highlighting the potential of ProScan to enhance the diagnostic process for small bowel bleeding.
Dr. Cristiano Spada, Professor of Gastroenterology at Gemelli Hospital in Rome, Italy, emphasized the significance of ProScan as a groundbreaking AI-assisted reading tool that improves the accuracy of small bowel bleeding detection while reducing reading times. The integration of ProScan into clinical practice has the potential to revolutionize gastrointestinal diagnostics and improve patient outcomes efficiently.
Stu Wildhorn, Vice President of Marketing and Product Management at AnX Robotica, highlighted the company’s commitment to advancing medical technology and supporting healthcare professionals in delivering the best possible care. AnX Robotica, founded in 2019, aims to provide user-friendly devices for diagnostic and therapeutic purposes, including the NaviCam SB with ProScan system.
The validation of ProScan in diagnosing small bowel bleeding represents a significant achievement in the field of gastrointestinal medicine. With its innovative AI technology, AnX Robotica is poised to transform the way healthcare professionals approach small bowel video capsule endoscopy, offering a more accurate and efficient solution for diagnosing gastrointestinal conditions.
